Elizabeth C. Verna
Elizabeth C. Verna
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SIPLIZUMAB in AILD and LT Patients | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Hepatitis, Chronic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, chronic liver failure, cirrhosis of liver, hepatitis, immune system disorder, liver disorder, liver failure, primary sclerosing cholangitis | Recruiting | Phase 1 | 2025-11-24 | NCT06455280 |